Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Eton Pharmaceuticals Inc's Business Segments
Eton Pharmaceuticals Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
1
Largest Segment
Product
Total Revenue
$ 38
Regions Reported
-
Revenue Share by Reportable Segment - FY
- Product0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 62 | - |
Revenue by Product & Service Category - FY
- Product Sales and Royalties0%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product Sales and Royalties | $ 24 | - |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Product0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 62 | - |
Description of Eton Pharmaceuticals Inc
Eton Pharmaceuticals Inc is a specialty pharmaceutical company that focuses on developing and commercializing innovative and targeted pharmaceutical products. The company is based in Deer Park, Illinois and was founded in 2013. Eton Pharmaceuticals aims to meet the unmet medical needs of patients and healthcare providers through the development of high-quality, cost-effective medications.
One of the key areas of focus for Eton Pharmaceuticals is the development of drug products using the U.S. Food and Drug Administration's (FDA) 505(b)(2) regulatory pathway. This pathway allows for the expedited development and approval of drugs that are modifications of previously approved products.
Eton Pharmaceuticals has a diverse portfolio of products across various therapeutic areas including neurology, critical care, and hospital-based injectables. The company has a team of experienced professionals in drug development, regulatory affairs, and commercialization who work collaboratively to bring these products to market.
The company's pipeline includes both branded and generic medications. This strategic combination allows Eton Pharmaceuticals to leverage its expertise in drug development and access a broader market. They work closely with contract manufacturing organizations to ensure the highest quality standards are met during the production of their pharmaceutical products.
Eton Pharmaceuticals places a strong emphasis on quality and compliance. They operate in strict compliance with Good Manufacturing Practices (GMP) and aim to consistently provide safe and effective medications to patients. The company also adheres to strict regulatory guidelines to ensure the approval, marketing, and distribution of their products are conducted in accordance with applicable laws and regulations.
In addition to their focus on drug development, Eton Pharmaceuticals also actively pursues partnerships and collaborations with other pharmaceutical companies and academic institutions. These collaborations enable the company to access new technologies, expand their product portfolio, and enhance their research and development capabilities.
Overall, Eton Pharmaceuticals Inc is a specialty pharmaceutical company dedicated to developing and commercializing innovative and targeted medications. They strive to improve patient outcomes by addressing unmet medical needs and delivering high-quality, cost-effective pharmaceutical products.
One of the key areas of focus for Eton Pharmaceuticals is the development of drug products using the U.S. Food and Drug Administration's (FDA) 505(b)(2) regulatory pathway. This pathway allows for the expedited development and approval of drugs that are modifications of previously approved products.
Eton Pharmaceuticals has a diverse portfolio of products across various therapeutic areas including neurology, critical care, and hospital-based injectables. The company has a team of experienced professionals in drug development, regulatory affairs, and commercialization who work collaboratively to bring these products to market.
The company's pipeline includes both branded and generic medications. This strategic combination allows Eton Pharmaceuticals to leverage its expertise in drug development and access a broader market. They work closely with contract manufacturing organizations to ensure the highest quality standards are met during the production of their pharmaceutical products.
Eton Pharmaceuticals places a strong emphasis on quality and compliance. They operate in strict compliance with Good Manufacturing Practices (GMP) and aim to consistently provide safe and effective medications to patients. The company also adheres to strict regulatory guidelines to ensure the approval, marketing, and distribution of their products are conducted in accordance with applicable laws and regulations.
In addition to their focus on drug development, Eton Pharmaceuticals also actively pursues partnerships and collaborations with other pharmaceutical companies and academic institutions. These collaborations enable the company to access new technologies, expand their product portfolio, and enhance their research and development capabilities.
Overall, Eton Pharmaceuticals Inc is a specialty pharmaceutical company dedicated to developing and commercializing innovative and targeted medications. They strive to improve patient outcomes by addressing unmet medical needs and delivering high-quality, cost-effective pharmaceutical products.
Eton Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing differentiated products, primarily in the areas of pediatrics and unmet medical needs. Their portfolio includes a range of segments, products, and services designed to address specific healthcare challenges, particularly those affecting vulnerable patient populations.
Segments
1. Pediatric Care: Eton Pharmaceuticals places heavy emphasis on pediatric formulations, recognizing that children often require medication that is both effective and suitable for their unique physiological characteristics. Their product development in this segment focuses on formulations that ensure ease of administration and optimal dosing for children.
2. Orphan Drugs: The company is involved in developing treatments for rare diseases, a segment that offers the potential for significant therapeutic advancements for patients with conditions that lack adequate treatment options. This includes exploring innovative formulations that may not have been previously available.
3. Controlled Substances: Eton is also engaged in the development of formulations for controlled substances. This includes both unique delivery mechanisms and formulations aimed at ensuring safer and more effective use of these medications.
4. Specialty Pharmacy Services: To complement its pharmaceutical offerings, Eton may provide specialized pharmacy services that tailor medication management and support for healthcare providers and patients, ensuring that they have the necessary tools and resources to utilize their products effectively.
Products
Etons product offerings may include:
1. Liquid Medications: Many of Etons products are liquid formulations specifically designed for children, which are easier to swallow compared to tablets or capsules. These formulations often incorporate flavors and sweeteners to improve palatability.
2. Orally Disintegrating Tablets (ODTs): These are designed to dissolve quickly in the mouth without the need for water. Eton may have developed ODTs that cater to pediatric patients or those with difficulty swallowing.
3. Multi-Dose Injectable Products: The company could be involved in creating injectable products that can be administered in aggregate doses to simplify treatment regimens for patients and reduce the burden on healthcare providers.
4. Novel Drug Formulations: Eton often focuses on reformulating existing drugs to improve their safety, efficacy, or ease of use. This process might involve changing the delivery mechanism, stability, or bioavailability of the drug to enhance clinical outcomes.
Services
In addition to their product offerings, Eton Pharmaceuticals may provide a range of services aimed at supporting their customers:
1. Regulatory Support: The company likely offers guidance and support throughout the regulatory approval process for new products, helping to navigate the complexities of FDA approvals and compliance.
2. Clinical Development Services: Eton might have in-house capabilities or partnerships that facilitate clinical trials, including designing study protocols and assisting in data analysis.
3. Market Access Support: Eton could provide services that assist healthcare providers and payers in understanding the value proposition of their products, facilitating market access and reimbursement strategies.
4. Patient Education and Support Programs: The company may offer resources and programs aimed at educating patients and healthcare professionals about their products, fostering better medication adherence and optimal usage.
5. Pharmacy Collaboration: They might engage in partnerships with pharmacy networks to ensure that their products are widely accessible and that pharmacists are adequately trained to counsel patients on the use of their medications.
Eton Pharmaceuticals continues to focus on innovative approaches to treating patients with specific needs, particularly in pediatric care and rare diseases, combining unique product offerings with comprehensive support services to improve patient outcomes.
Segments
1. Pediatric Care: Eton Pharmaceuticals places heavy emphasis on pediatric formulations, recognizing that children often require medication that is both effective and suitable for their unique physiological characteristics. Their product development in this segment focuses on formulations that ensure ease of administration and optimal dosing for children.
2. Orphan Drugs: The company is involved in developing treatments for rare diseases, a segment that offers the potential for significant therapeutic advancements for patients with conditions that lack adequate treatment options. This includes exploring innovative formulations that may not have been previously available.
3. Controlled Substances: Eton is also engaged in the development of formulations for controlled substances. This includes both unique delivery mechanisms and formulations aimed at ensuring safer and more effective use of these medications.
4. Specialty Pharmacy Services: To complement its pharmaceutical offerings, Eton may provide specialized pharmacy services that tailor medication management and support for healthcare providers and patients, ensuring that they have the necessary tools and resources to utilize their products effectively.
Products
Etons product offerings may include:
1. Liquid Medications: Many of Etons products are liquid formulations specifically designed for children, which are easier to swallow compared to tablets or capsules. These formulations often incorporate flavors and sweeteners to improve palatability.
2. Orally Disintegrating Tablets (ODTs): These are designed to dissolve quickly in the mouth without the need for water. Eton may have developed ODTs that cater to pediatric patients or those with difficulty swallowing.
3. Multi-Dose Injectable Products: The company could be involved in creating injectable products that can be administered in aggregate doses to simplify treatment regimens for patients and reduce the burden on healthcare providers.
4. Novel Drug Formulations: Eton often focuses on reformulating existing drugs to improve their safety, efficacy, or ease of use. This process might involve changing the delivery mechanism, stability, or bioavailability of the drug to enhance clinical outcomes.
Services
In addition to their product offerings, Eton Pharmaceuticals may provide a range of services aimed at supporting their customers:
1. Regulatory Support: The company likely offers guidance and support throughout the regulatory approval process for new products, helping to navigate the complexities of FDA approvals and compliance.
2. Clinical Development Services: Eton might have in-house capabilities or partnerships that facilitate clinical trials, including designing study protocols and assisting in data analysis.
3. Market Access Support: Eton could provide services that assist healthcare providers and payers in understanding the value proposition of their products, facilitating market access and reimbursement strategies.
4. Patient Education and Support Programs: The company may offer resources and programs aimed at educating patients and healthcare professionals about their products, fostering better medication adherence and optimal usage.
5. Pharmacy Collaboration: They might engage in partnerships with pharmacy networks to ensure that their products are widely accessible and that pharmacists are adequately trained to counsel patients on the use of their medications.
Eton Pharmaceuticals continues to focus on innovative approaches to treating patients with specific needs, particularly in pediatric care and rare diseases, combining unique product offerings with comprehensive support services to improve patient outcomes.